Kumiko Kato
R&D Division, Next Generation Science Institute, Morinaga Milk Industry Co., Ltd., Zama, Japan
- Papers in database
- 7
- Primary author
- 1 paper
- Years active
- 2018 – 2024
- Health outcomes studied
- 2
Health Outcomes Studied
Papers (7)
- 2024Bifidobacterium breve M-16V regulates the autonomic nervous system via the intestinal environment: A double-blind, placebo-controlled study.10.1016/j.bbr.2023.114820
- 2024Effects of <i>Bifidobacterium longum</i> BB536 and <i>Bifidobacterium breve</i> MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study.10.3390/nu16060815
- 2024The Impact of Fermented Milk Products Containing <i>Bifidobacterium longum</i> BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial.10.3390/nu16213580
- 2024Primary authorEffects of Heat-Killed <i>Lacticaseibacillus paracasei</i> MCC1849 on Immune Parameters in Healthy Adults-A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.10.3390/nu16020216
- 2023The Potential Immunomodulatory Effect of Bifidobacterium longum subsp. longum BB536 on Healthy Adults through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood10.3390/nu16010042
- 2020Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol10.1371/journal.pone.0238923
- 2018Genomic diversity and distribution of Bifidobacterium longum subsp. longum across the human lifespan10.1038/s41598-017-18391-x